StonvexLoading…
StonvexCore line items from CHPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-05-28 | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|---|
Revenue | $98.35M | $411.22M | $301.90M | $196.23M | $97.64M |
Operating Income | Not available | $-210.14M | $-157.15M | $-112.82M | $-53.84M |
Net Income | Not available | $-220.20M | $-175.78M | $-66.18M | $-57.12M |
EPS (Diluted) | $-1.04 | $-9.41 | $-7.57 | $-5.34 | $-0.12 |
Total Assets | Not available | $792.25M | $848.03M | $870.25M | $897.61M |
Total Liabilities | Not available | $770.95M | $809.65M | $799.54M | $779.02M |
Cash & Equivalents | Not available | $141.56M | $180.51M | $194.12M | $195.95M |
Free Cash Flow OCF − CapEx | Not available | $-67.00M | $-65.03M | $-41.48M | $-34.03M |
Shares Outstanding | Not available | 24.32M | 23.65M | 23.36M | 461.65M |